(E)-{1-[3-(4-chlorophenyl)-1,2-oxazol-5-yl]ethylidene}amino 3-(trifluoromethyl)benzoate

Catalog No. :
ACLVEG103
CAS No. :
478066-84-1
Molecular Formula :
C19H12ClF3N2O3
Molecular Weight :
408.76

IUPAC Name:(E)-1-(3-(4-chlorophenyl)isoxazol-5-yl)ethan-1-one O-(3-(trifluoromethyl)benzoyl) oxime

(E)-{1-[3-(4-chlorophenyl)-1,2-oxazol-5-yl]ethylidene}amino 3-(trifluoromethyl)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-{1-[3-(4-chlorophenyl)-1,2-oxazol-5-yl]ethylidene}amino 3-(trifluoromethyl)benzoate
IUPAC Name(E)-1-(3-(4-chlorophenyl)isoxazol-5-yl)ethan-1-one O-(3-(trifluoromethyl)benzoyl) oxime
Molecular FormulaC19H12ClF3N2O3
Molecular Weight408.76
SMILESO=C(O/N=C(C1=CC(C2=CC=C(Cl)C=C2)=NO1)\C)C3=CC=CC(C(F)(F)F)=C3
InChI KeyBXPXBKMUXPHJIP-BHGWPJFGSA-N
SynonymN-((E)-1-[3-(4-CHLOROPHENYL)-5-ISOXAZOLYL]ETHYLIDENE)-N-([3-(TRIFLUOROMETHYL)BENZOYL]OXY)AMINE;3-(4-CHLOROPHENYL)-5-(([3-(TRIFLUOROMETHYL)BENZOYL]OXY)ETHANIMIDOYL)ISOXAZOLE;(E)-{1-[3-(4-chlorophenyl)-1,2-oxazol-5-yl]ethylidene}amino 3-(trifluoromethyl)benzoate;Ethanone, 1-[3-(4-chlorophenyl)-5-isoxazolyl]-, O-[3-(trifluoromethyl)benzoyl]oxime
CAS No.478066-84-1

Synthetic Route by SureRoute

1. ACLVEG103 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLVEG103 route product structure diagram
    ACLVEG103478066-84-1
Inquiry

2. ACLVEG103 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLVEG103 route product structure diagram
    ACLVEG103478066-84-1
Inquiry

Comments (0)